Drug monographs are focused scientific documents that typically pertain to a specific active ingredient or combination product. Monographs provide factual information that is needed for the safe and effective use of a product in patients. Monographs are used in multiple settings, from formulary decision-making to practice at the bedside.
Med Communications’ scientific content team develops drug monographs that are a robust extension of the approved prescribing information. Monographs are organized in a succinct and logical manner. This allows for quick and easy navigation and location of the information necessary for making informed and evidence-based clinical decisions. Representative sections of a monograph generally include:
- Pivotal trials
- Dosing (general and special populations)
- Warnings and adverse effects
- Drug interactions
- Properties and stability
Content can be customized to include additional sections (e.g., therapeutic class, pertinent guideline information, compatibility) and to accommodate various use cases (e.g., condensed information for point-of-care applications, comparison information with other similar products). Our team’s clinical experience, industry knowledge, and therapeutic area expertise inform our work, allowing us to anticipate the needs of clinicians and key stakeholders alike.